Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Yasmin Settlements Climb to $142 Million

(EMAILWIRE.COM, May 18, 2012 ) New York, NY – Yasmin settlements have climbed to $142 million, averaging $218,000 per case, according to a number of news sources. Bayer has reportedly resolved 651 lawsuits alleging that its Yasmin and Yaz birth control pills caused sometimes-fatal blood clots in women, with one financial analyst reportedly estimating that Bayer may have to pay out more than $2.65 billion to resolve all cases surrounding these oral contraceptives. If you or a loved one suffered a blood clot while taking Yaz or Yasmin, you may still be able to file a claim against the manufacturer to seek compensation for medical expenses and other losses. To learn more about the Yasmin settlements and to have your claim evaluated at no cost to you, please visit http://www.classaction.org/yaz-yasmin.html today.

The news of the Yasmin settlements came shortly after the FDA ordered a stronger blood clot warning on Yaz and Yasmin labels. The new labels will include information that some studies have found up to a threefold increase in the risk of blood clots with pills containing drospirenone, a hormone found in Yaz, Yasmin and other newer, fourth-generation birth control pills. The agency’s own study found that 10 in 10,000 women taking oral contraceptives containing this synthetic hormone would get a blood clot per year, compared to approximately six in 10,000 women using older birth control pills. This announcement of the label update was made after an advisory committee of outside experts to the agency voted for pills containing drospirenone to undergo a label revision to more clearly outline their risks and benefits.

Reportedly, Bayer is facing 11,900 lawsuits over its Yaz and Yasmin oral contraceptives. Bayer has agreed to settle the first group of lawsuits for venous clot injuries – deep vein thrombosis (DVT) or pulmonary embolism (PE) - while other suits are still in progress. If you suffered a venous clot injury while taking Yaz or Yasmin, it’s not too late to make a claim. For a free evaluation of your blood clot claim, visit ClassAction.org today.

About Class Action.org

Class Action.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. Class Action.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit http://www.classaction.org today for a no cost, no obligation case evaluation and information about your consumer rights.

ClassAction.org
Hannah Armstrong
800-449-1970
pressrelease@lawyercentral.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo! News
Health News Headlines - Yahoo! News
Get the latest health news headlines from Yahoo! News. Find breaking health news, including analysis and opinion on top health stories.


Cancer Society hits 100 as US cancer rate falls
22 May 2013 at 12:14am

NEW YORK (AP) ? The American Cancer Society ? one of the nation's best known and influential health advocacy groups ? is 100 years old this week.



Polish man gets quick face transplant after injury
22 May 2013 at 8:46am

WARSAW, Poland (AP) ? A 33-year-old Polish man received a face transplant just three weeks after being disfigured in a workplace accident, in what his doctors said Wednesday is the fastest time frame to date for such an operation.


Portland, Ore., rejecting water fluoridation
21 May 2013 at 11:58pm
PORTLAND, Ore. (AP) ? The mayor of Portland, Ore., has conceded defeat in an effort to add fluoride to the city's drinking water.


Pfizer to spin off Zoetis stake to shareholders
22 May 2013 at 8:57am

(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount. Pfizer, the largest U.S. drugmaker, sold Zoetis shares in an initial public offering in February that raised $2.2 billion. Pfizer retained an 80 percent stake in Zoetis after the IPO and now plans to unwind that, starting with this offer. ...


More doctors, hospitals using electronic records
22 May 2013 at 7:47am
WASHINGTON (AP) ? The Obama administration says more doctors and hospitals are embracing technology as adoption of computerized medical records reaches a "tipping point" in America.


Life-saving face transplant performed in Poland
22 May 2013 at 7:33am

WARSAW, Poland (AP) ? A 33-year-old Polish man received a life-saving total face transplant just three weeks after being disfigured in a workplace accident, in what his doctors said Wednesday is the fastest timeframe to date for such an operation.


Synthetic Peas Soothe Achy Joints
22 May 2013 at 6:56am
Sir Isaac Newton found his inspiration in an apple.  MaryCarol Dolivier found hers in a bag of frozen peas. After Dolivier tumbled down a flight of stairs a few years ago she was forced to lay on the couch for several weeks, a bag of...        

Oncolytics cancer drug meets mid-stage trial goal, shares rise
22 May 2013 at 6:46am
(Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with metastatic melanoma, a type of skin cancer. Shares of the Calgary-based company rose as much as 11 percent to C$3.14 on the Toronto Stock Exchange on Wednesday. Its Nasdaq-listed shares were up 10 percent. ...


Swiss billionaires buy Merck Serono HQ for biotech campus
22 May 2013 at 6:43am

By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker Merck KGaA for $13.3 billion in 2006, the Harvard Business School graduate went on to win the America's Cup sailing prize for the second time. He and his former beauty queen wife Kirsty cut a high profile among the Swiss jet-set. ...



U.S. government taps GlaxoSmithKline for new antibiotics
22 May 2013 at 6:30am

By Ben Hirschler LONDON (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism. The collaboration, the first of its kind between Washington and a drug company, will allow funding to move around GSK's antibiotics portfolio rather than focusing on a single drug candidate. ...



When it comes to deadly viruses, what's in a name?
22 May 2013 at 5:54am

By Kate Kelland, Health and Science Correspondent LONDON (Reuters) - For a pathogen with such a short history, the mysterious new virus killing people in the Middle East and Europe has already had an amazing array of names. It first surfaced last year as "human betacoronavirus 2c EMC", but the suffixes "2c England-Qatar, "2C Jordan-N3", "England 1" have also appeared and many scientists have resorted to "novel coronavirus" - new crown-shaped virus - instead. ...


Google CEO s Condition Spotlights Vocal Cord Paralysis and Its Treatment
22 May 2013 at 4:30am
Google CEO s Condition Spotlights Vocal Cord Paralysis and Its Treatment


Prolonging the buzz with Grandma
22 May 2013 at 4:28am

Prolonging the buzz with Grandma



Los Angeles voters OK move to curtail medical marijuana outlets
22 May 2013 at 3:54am

By Alex Dobuzinskis LOS ANGELES (Reuters) - Voters strongly supported a ballot measure to sharply curtail the number of medical marijuana dispensaries permitted to operate in Los Angeles while boosting taxes on the sale of pot for health reasons, election returns early on Wednesday showed. The proposal appeared headed for passage. Returns showed 63 percent of voters supporting it compared with 37 percent opposed, after tabulation of more than 40 percent of ballots cast at polling stations on Tuesday, and all of the mail-in ballots received as of last Friday. ...


Immune system cancer drugs tipped to be a $35 billion market
22 May 2013 at 2:48am
By Ben Hirschler LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank Citigroup highlights the growing excitement surrounding so-called immunotherapy after positive results from clinical trials conducted by companies such as Bristol-Myers Squibb and Roche Holding. ...

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC